rxstatShortages › Clindamycin

Clindamycin shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Clindamycin products are in shortage in Canada (5 of 28 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
Products affected
5 / 28
In shortage since
Nov 9, 2017
Reports on file
125
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
DALACIN VAGINAL CREAM
20MG · CREAM · PFIZER CANADA ULC
DIN 02060604 · since May 7, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-CLINDAMYCIN
300MG · CAPSULE · TEVA CANADA LIMITED
DIN 02241710 · since Jan 21, 2026, no end estimate · Other (Please describe in comments)
Active shortage
TEVA-CLINDAMYCIN
150MG · CAPSULE · TEVA CANADA LIMITED
DIN 02241709 · since Oct 8, 2025, no end estimate · Other (Please describe in comments)
Active shortage
CLINDA-T
1% · SOLUTION · VALEANT CANADA LP/VALEANT CANADA S.E.C.
DIN 02243659 · since Nov 9, 2017, no end estimate · Disruption of the manufacture of the drug.
Active shortage
DALACIN T 1%
1% · SOLUTION · PFIZER CANADA INC
DIN 00582301 · since Jan 26, 2018, no end estimate · Disruption of the manufacture of the drug.
Active shortage
DALACIN T 1%
1% · SOLUTION · PFIZER CANADA INC
DIN 00582301 · since Jan 26, 2018, no end estimate · Disruption of the manufacture of the drug.
To be discontinued
TARO-CLINDAMYCIN
1% · SOLUTION · TARO PHARMACEUTICALS INC
DIN 02266938
Resolved
DALACIN VAGINAL CREAM
20MG · CREAM · PFIZER CANADA ULC
DIN 02060604 · ended Apr 10, 2026 · Disruption of the manufacture of the drug.
Resolved
TARO-CLINDAMYCIN
1% · SOLUTION · TARO PHARMACEUTICALS INC
DIN 02266938 · ended Mar 23, 2026 · Disruption of the manufacture of the drug.
Resolved
CLINDAMYCIN IV INFUSION
12MG · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02408511 · ended Mar 9, 2026 · Delay in shipping of the drug.
Resolved
TARO-CLINDAMYCIN
1% · SOLUTION · TARO PHARMACEUTICALS INC
DIN 02266938 · ended Mar 17, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-CLINDAMYCIN
300MG · CAPSULE · TEVA CANADA LIMITED
DIN 02241710 · ended Dec 17, 2025 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Clindamycin is currently affected by 5 active shortage reports filed with Health Canada by PFIZER CANADA ULC, TEVA CANADA LIMITED, VALEANT CANADA LP/VALEANT CANADA S.E.C., PFIZER CANADA INC.

The reported causes are: disruption of the manufacture of the drug; other (please describe in comments). Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Clindamycin is classified under “ANTI-ACNE PREPARATIONS FOR TOPICAL USE” (ATC D10AF).

Recent changes

Common questions

When will Clindamycin be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Clindamycin in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (anti-acne preparations for topical use)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.